SequelSEC

Genprex, Inc. GNPX

Pharmaceutical Preparations · CIK 0001595248 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2024-12-31
Operating income
Unavailable
Fiscal year ended 2024-12-31
Free cash flow
Unavailable
Fiscal year ended 2024-12-31

This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Genprex, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Genprex, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-31
RevenueUnavailableUnavailable$0$0$0$0$0$0$0$0
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating incomeUnavailableUnavailable-$6.58M-$6.17M-$5.77M-$5.31M-$6.75M-$3.44M-$3.99M-$5.31M
Net incomeUnavailableUnavailable-$6.52M-$6.14M-$5.76M-$5.31M-$6.75M-$3.44M-$3.99M-$5.31M
Research & developmentUnavailableUnavailable$3.39M$3.16M$2.93M$2.04M$3.84M$1.43M$1.53M$2.04M
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrativeUnavailableUnavailable$3.19M$3.01M$2.84M$3.26M$2.90M$2.00M$2.46M$3.26M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Genprex, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-31
Cash & equivalents$1.60M$6.74M$20.95M$25.52M$30.05M$34.56M$38.63M$42.02M$44.24MUnavailable
Total assets$4.12M$10.67M$25.09M$29.95M$34.57M$39.41M$42.86M$46.33M$48.73M$51.04M
Current assets$2.08M$7.53M$21.47M$26.31M$30.90M$35.70M$39.14M$45.64M$48.06M$50.38M
Total liabilities$2.50MUnavailableUnavailable$2.46M$2.15M$2.38M$1.59MUnavailableUnavailableUnavailable
Current liabilities$2.50M$3.25M$2.81M$2.46M$2.15M$2.38M$1.59M$1.16M$1.05M$613.63K
Total equity incl. NCI$1.62M$7.42M$22.27M$27.49M$32.41M$37.02M$41.28M$45.17M$47.68M$50.42M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailable$0$34.85K$34.85KUnavailable$32.17K$0$127$127$127
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

Genprex, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-31
Operating cash flowUnavailableUnavailable-$4.55M-$4.52M-$4.48M-$4.07M-$3.22M-$2.63M-$2.97M-$5.47M
Capital expendituresUnavailableUnavailable$0$0$0$0$11.22K$11.34K-$82.56K$91.70K
Investing cash flowUnavailableUnavailable-$20.00K-$16.05K-$21.85K-$1.84K-$173.58K$168.29K$31.52K-$110.03K
Financing cash flowUnavailableUnavailable$4.67K$1.75K$0$0$0$243.55K$110.03K$25.32M
Net change in cashUnavailableUnavailable-$4.56M-$4.54M-$4.50M-$4.07M-$3.39M-$2.22M-$2.83M$19.75M
Stock-based compensationUnavailableUnavailable$1.31M$1.22M$1.15M$1.06M$2.86M$675.38K$1.14M$671.74K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

Genprex, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-12-312023-12-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable-$3.23M-$2.65MUnavailable-$5.56M
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio0.83x2.31x7.64x10.71x14.35x14.97x24.69x39.28x45.89x82.10x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GNPX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-30View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-12View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.